ANIK Financial Facts
Research & development: 2.82MNet income: 8.95M
See Full Income Statement
Total Assets: 231.06M
Intangible assets, net: 11.17M
See Full Balance Sheet
Anika Therapeutics Inc. (ANIK) Earnings
|
Expand Research on ANIK
| Next EPS Date | 5/8/24 | EPS Growth Rate | -63.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +98.7% | Revenue Growth Rate | +9.6% |
| Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24  |
Q124 | N/A | -$0.18 | N/A | N/A | $41.55M | = | N/A | N/A | ||
| 2/22/24 | Q423 | N/A | -$0.23 | N/A | N/A | $41.4M | = | N/A | N/A | ||
| 2/26/24 | Q423 | N/A | -$0.23 | N/A | N/A | $41.4M | = | N/A | N/A | ||
| 3/13/24 | Q423 | $0.05 | -$0.23 | +$0.28 | $43M | $41.4M | = |  | | Details | |
| 11/2/23 | Q323 | $0.00 | -$0.35 | +$0.35 | $41.5M | $38.27M | = | | | Details | |
| 8/8/23 | Q223 | $0.06 | -$0.32 | +$0.38 | $44.3M | $40.37M | = | | | Details | |
| 5/9/23 | Q123 | -$0.11 | -$0.24 | +$0.13 | $37.9M | $38.95M | = | | | Details | |
| 2/23/23 | Q422 | N/A | -$0.24 | N/A | N/A | $37.71M | N/A | N/A | N/A |
